home / stock / etnb / etnb news

ETNB News and Press, 89bio Inc. From 03/15/24

Stock Information
Company Name: 89bio Inc.
Stock Symbol: ETNB
Market: NYSE
Website: 89bio.com
Menu
ETNB ETNB Quote ETNB Short ETNB News ETNB Articles ETNB Message Board
Get ETNB Alerts

News, Short Squeeze, Breakout and More Instantly...
ETNB - AVLX, SGH and ETNB are among pre market losers

2024-03-15 16:48:33 ET Gainers: 89bio  ( ETNB ) +5% . Black Diamond Therapeutics ( BDTX ) +5% . Anavex Life Sciences  ( AVXL ) +3% . iHeartMedia ( IHRT ) +2% . SMART Global Holdings ( SGH ) +2% . Losers: CERo Th...
ETNB - Madrigal climbs amid hopes for new NASH drug; B. Riley upgrades

2024-03-15 08:19:55 ET More on Madrigal Pharmaceuticals Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Rating Downgrade) Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's...

ETNB - Madrigal wins FDA approval for NASH therapy

2024-03-14 15:45:17 ET More on Madrigal Pharmaceuticals Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Rating Downgrade) Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's...

ETNB - Madrigal and liver drug developers fall ahead of FDA decision on NASH therapy

2024-03-14 10:42:03 ET More on Madrigal Pharma Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Rating Downgrade) Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's Potentia...
ETNB - Liver drug developers outperform as U.S. awaits first NASH drug

2024-03-13 13:29:04 ET More on Madrigal Pharmaceuticals Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Rating Downgrade) Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's...

ETNB - Ionis stock jumps as MASH drug succeeds in mid-stage trial

2024-03-13 08:00:58 ET Ionis Pharmaceuticals ( NASDAQ: IONS ) shares rose in early trading on Wednesday after the company reported positive results from a mid-stage trial of its investigational drug to treat a type of fatty liver disease.... Read the full article on S...

ETNB - 89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Fibrosis

—Co-primary endpoints in ENLIGHTEN-Fibrosis assessed at week 52 will potentially support accelerated approval in non-cirrhotic MASH (fibrosis stage F2-F3) patients— —ENLIGHTEN-Cirrhosis, the second trial in the program, is planned to evaluate patients with compensat...
ETNB - 89bio to Participate in the Leerink Partners Global Biopharma Conference

SAN FRANCISCO, March 05, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Company’s Mana...

ETNB - 89bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates

– Plan to initiate the Phase 3 ENLIGHTEN NASH program for non-cirrhotic (F2-F3) and cirrhotic (F4) patients in the first and second quarters of 2024, respectively – – Long-term data from Phase 2b ENLIVEN trial demonstrated sustained benefits of pegozafermin at w...

ETNB - ETNB, IHRT and AGYS are among after hour movers

2024-02-14 16:47:15 ET Gainers: SoundHound ( SOUN ) +17% . JFrog  ( FROG ) +11% . Applovin Corporation ( APP ) +8% . iHeartMedia ( IHRT ) +6% . TripAdvisor ( TRIP ) +5% . Losers: Udemy ( UDMY ) -16% . Ner...
Previous 10 Next 10